Sysmex Europe Launches Automated Blood Testing Platform for Alzheimer’s Disease
The system uses routine blood draws to provide results in 17 minutes, offering an alternative to invasive diagnostic methods.
The system uses routine blood draws to provide results in 17 minutes, offering an alternative to invasive diagnostic methods.
Agilent Technologies has partnered with OpenAI and Boston Consulting Group to accelerate artificial intelligence deployment in lab workflows, aiming to deliver faster scientific insights and advance intelligent instruments, software, and services.
A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
The FDA has granted Breakthrough Device Designation to Valar Labs’ Vesta Bladder Risk Stratify Dx, the first AI-powered digital pathology prognostic test for bladder cancer.
The initiative aims to standardize digital pathology through an open-source platform and image management system.
Researchers identify molecular markers in saliva that could lead to new clinical tests for sleep loss.
Bio-Rad has expanded its TrailBlazer StarBright Dye Label Kits to 32 options, now available in Europe for flow cytometry and fluorescent western blot applications, according to the company.
The XR-Series features higher throughput and enhanced analytics to streamline daily laboratory operations.
Roche has received CE mark approval for its Elecsys pTau217 blood test, designed to aid in Alzheimer’s disease diagnosis by detecting amyloid pathology in patients with cognitive decline.
The new triple quadrupole mass spectrometry system aims to increase sample throughput and simplify interference removal.
The panel detects fungal DNA in plasma to help identify specific pathogens in immunocompromised patients.
Monitoring circulating tumor DNA dynamics outperformed standard markers for predicting survival and relapse in early-stage patients.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.